Category: <span>Pharmaceutical Updates</span>

Home / Pharmaceutical Updates
New model sheds light on the chemistry surrounding peptide helices
Post

New model sheds light on the chemistry surrounding peptide helices

News Release 16-Sep-2024 Peer-Reviewed PublicationCenter for Research in Biological Chemistry and Molecular Materials (CiQUS) image: Dr. Julián Bergueiro at CiQUS: Credit: CiQUS – USC Helices are structures found naturally in many important molecules, such as proteins. These helices possess a twist that depends on the arrangement of their basic components. By understanding how a helix...

Post

Reduced Risk for Peripheral Neuropathy Tied to Diabetes Medication

Kate Johnson June 25, 2024 MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also help prevent diabetic peripheral neuropathy (DPN), new research suggests. In a large database analysis of patients with type 2 diabetes, those taking tirzepatide had...

FDA says drug makers will stop producing fentanyl ‘lollipops’by Robin Foster
Post

FDA says drug makers will stop producing fentanyl ‘lollipops’by Robin Foster

September 20, 2024 by Robin Foster Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced. Known as TIRF medications, these products contain fentanyl and are used to manage breakthrough pain in cancer patients who have become tolerant to around-the-clock opioid therapy, the...

Tirzepatide associated with greater weight loss in women than men
Post

Tirzepatide associated with greater weight loss in women than men

September 11, 2024 by Diabetologia Credit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of the...

Weight loss drug liraglutide is safe and effective in children under 12, study finds
Post

Weight loss drug liraglutide is safe and effective in children under 12, study finds

September 10, 2024 by Diabetologia Credit: Lukas from PexelsThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of...

Sickle cell patients given Lactated Ringer’s solution for pain improve more easily than those given normal saline
Post

Sickle cell patients given Lactated Ringer’s solution for pain improve more easily than those given normal saline

September 9, 2024 by Boston University School of Medicine Credit: National Institutes of HealthSickle cell disease is a common genetic disorder characterized by periodic occurrences of pain that occur repeatedly throughout life. These episodes, referred to as vaso-occlusive episodes, happen when sickled cells obstruct blood vessels. The degree of pain may range from a mild...

Chronic steroid use could raise diabetes risk
Post

Chronic steroid use could raise diabetes risk

September 10, 2024 by Dennis Thompson Taking steroids more than doubles a person’s risk of developing type 2 diabetes, a new study warns. Patients taking steroid pills, injections or infusions are 2.6 times more likely to develop diabetes than those not on steroids, researchers reported Sunday in a presentation at the annual meeting of the...